Client & Alumni News

Cernostics Raises $2.5 Million in Series A1 Financing

Cernostics, a BFTP client focused on delivering next-generation cancer diagnostics and prognostics, raised $2.5 million in Series A1 financing, led by Illumina Ventures. With this capital investment, Cernostics will be able to intensify its clinical and market development for its TissueCypher® Barrett’s Esophagus Assay — the first test of its kind to predict the risk of development of deadly esophageal cancer in patients with Barrett’s esophagus. More